ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global B-Cell Non-Hodgkin's Lymphoma Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-15X10114
Home | Market Reports | Health| Health Conditions| Cancer
Global B Cell Non Hodgkin s Lymphoma Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global B-Cell Non-Hodgkin's Lymphoma Drug Market Research Report 2025

Code: QYRE-Auto-15X10114
Report
July 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Gilead Sciences
TG Therapeutics
Bayer
Secura Bio
EpiZyme Inc
Eisai Co Ltd
Acrotech Biopharma
TEVA
Eagle Pharmaceuticals
Mundipharma

B-Cell Non-Hodgkin's Lymphoma Drug Market Size

The global market for B-Cell Non-Hodgkin's Lymphoma Drug was valued at US$ 8990 million in the year 2024 and is projected to reach a revised size of US$ 14530 million by 2031, growing at a CAGR of 7.2% during the forecast period.

B-Cell Non-Hodgkin's Lymphoma Drug Market

B-Cell Non-Hodgkin's Lymphoma Drug Market

Non-Hodgkin"s lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body"s germ-fighting immune system. In non-Hodgkin"s lymphoma, white blood cells called lymphocytes grow abnormally and can form growths (tumors) throughout the body.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for B-Cell Non-Hodgkin's Lymphoma Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding B-Cell Non-Hodgkin's Lymphoma Drug.
The B-Cell Non-Hodgkin's Lymphoma Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global B-Cell Non-Hodgkin's Lymphoma Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the B-Cell Non-Hodgkin's Lymphoma Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of B-Cell Non-Hodgkin's Lymphoma Drug Market Report

Report Metric Details
Report Name B-Cell Non-Hodgkin's Lymphoma Drug Market
Accounted market size in year US$ 8990 million
Forecasted market size in 2031 US$ 14530 million
CAGR 7.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Oral
  • Injection
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Gilead Sciences, TG Therapeutics, Bayer, Secura Bio, Epizyme, Eisai, Acrotech Biopharma, Teva, Eagle Pharmaceuticals, MundiPharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of B-Cell Non-Hodgkin's Lymphoma Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is B-Cell Non-Hodgkin's Lymphoma Drug Market growing?

Ans: The B-Cell Non-Hodgkin's Lymphoma Drug Market witnessing a CAGR of 7.2% during the forecast period 2025-2031.

What is the B-Cell Non-Hodgkin's Lymphoma Drug Market size in 2031?

Ans: The B-Cell Non-Hodgkin's Lymphoma Drug Market size in 2031 will be US$ 14530 million.

Who are the main players in the B-Cell Non-Hodgkin's Lymphoma Drug Market report?

Ans: The main players in the B-Cell Non-Hodgkin's Lymphoma Drug Market are Roche, Gilead Sciences, TG Therapeutics, Bayer, Secura Bio, Epizyme, Eisai, Acrotech Biopharma, Teva, Eagle Pharmaceuticals, MundiPharma

What are the Application segmentation covered in the B-Cell Non-Hodgkin's Lymphoma Drug Market report?

Ans: The Applications covered in the B-Cell Non-Hodgkin's Lymphoma Drug Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the B-Cell Non-Hodgkin's Lymphoma Drug Market report?

Ans: The Types covered in the B-Cell Non-Hodgkin's Lymphoma Drug Market report are Oral, Injection

Recommended Reports

Lymphoma and Leukemia

Hematological Disorders

Cancer and Oncology

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Perspective (2020-2031)
2.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Growth Trends by Region
2.2.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 B-Cell Non-Hodgkin's Lymphoma Drug Historic Market Size by Region (2020-2025)
2.2.3 B-Cell Non-Hodgkin's Lymphoma Drug Forecasted Market Size by Region (2026-2031)
2.3 B-Cell Non-Hodgkin's Lymphoma Drug Market Dynamics
2.3.1 B-Cell Non-Hodgkin's Lymphoma Drug Industry Trends
2.3.2 B-Cell Non-Hodgkin's Lymphoma Drug Market Drivers
2.3.3 B-Cell Non-Hodgkin's Lymphoma Drug Market Challenges
2.3.4 B-Cell Non-Hodgkin's Lymphoma Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top B-Cell Non-Hodgkin's Lymphoma Drug Players by Revenue
3.1.1 Global Top B-Cell Non-Hodgkin's Lymphoma Drug Players by Revenue (2020-2025)
3.1.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Players (2020-2025)
3.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by B-Cell Non-Hodgkin's Lymphoma Drug Revenue
3.4 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Concentration Ratio
3.4.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by B-Cell Non-Hodgkin's Lymphoma Drug Revenue in 2024
3.5 Global Key Players of B-Cell Non-Hodgkin's Lymphoma Drug Head office and Area Served
3.6 Global Key Players of B-Cell Non-Hodgkin's Lymphoma Drug, Product and Application
3.7 Global Key Players of B-Cell Non-Hodgkin's Lymphoma Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 B-Cell Non-Hodgkin's Lymphoma Drug Breakdown Data by Type
4.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Historic Market Size by Type (2020-2025)
4.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Forecasted Market Size by Type (2026-2031)
5 B-Cell Non-Hodgkin's Lymphoma Drug Breakdown Data by Application
5.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Historic Market Size by Application (2020-2025)
5.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2020-2031)
6.2 North America B-Cell Non-Hodgkin's Lymphoma Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025)
6.4 North America B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2020-2031)
7.2 Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025)
7.4 Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2020-2031)
8.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2020-2031)
9.2 Latin America B-Cell Non-Hodgkin's Lymphoma Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025)
9.4 Latin America B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2020-2031)
10.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche B-Cell Non-Hodgkin's Lymphoma Drug Introduction
11.1.4 Roche Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Introduction
11.2.4 Gilead Sciences Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
11.2.5 Gilead Sciences Recent Development
11.3 TG Therapeutics
11.3.1 TG Therapeutics Company Details
11.3.2 TG Therapeutics Business Overview
11.3.3 TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Introduction
11.3.4 TG Therapeutics Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
11.3.5 TG Therapeutics Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer B-Cell Non-Hodgkin's Lymphoma Drug Introduction
11.4.4 Bayer Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
11.4.5 Bayer Recent Development
11.5 Secura Bio
11.5.1 Secura Bio Company Details
11.5.2 Secura Bio Business Overview
11.5.3 Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Introduction
11.5.4 Secura Bio Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
11.5.5 Secura Bio Recent Development
11.6 Epizyme
11.6.1 Epizyme Company Details
11.6.2 Epizyme Business Overview
11.6.3 Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Introduction
11.6.4 Epizyme Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
11.6.5 Epizyme Recent Development
11.7 Eisai
11.7.1 Eisai Company Details
11.7.2 Eisai Business Overview
11.7.3 Eisai B-Cell Non-Hodgkin's Lymphoma Drug Introduction
11.7.4 Eisai Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
11.7.5 Eisai Recent Development
11.8 Acrotech Biopharma
11.8.1 Acrotech Biopharma Company Details
11.8.2 Acrotech Biopharma Business Overview
11.8.3 Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Introduction
11.8.4 Acrotech Biopharma Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
11.8.5 Acrotech Biopharma Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva B-Cell Non-Hodgkin's Lymphoma Drug Introduction
11.9.4 Teva Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
11.9.5 Teva Recent Development
11.10 Eagle Pharmaceuticals
11.10.1 Eagle Pharmaceuticals Company Details
11.10.2 Eagle Pharmaceuticals Business Overview
11.10.3 Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Introduction
11.10.4 Eagle Pharmaceuticals Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
11.10.5 Eagle Pharmaceuticals Recent Development
11.11 MundiPharma
11.11.1 MundiPharma Company Details
11.11.2 MundiPharma Business Overview
11.11.3 MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Introduction
11.11.4 MundiPharma Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
11.11.5 MundiPharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Roche
Gilead Sciences
TG Therapeutics
Bayer
Secura Bio
EpiZyme Inc
Eisai Co Ltd
Acrotech Biopharma
TEVA
Eagle Pharmaceuticals
Mundipharma
List of Tables
 Table 1. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oral
 Table 3. Key Players of Injection
 Table 4. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Region (2020-2025)
 Table 8. Global B-Cell Non-Hodgkin's Lymphoma Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Region (2026-2031)
 Table 10. B-Cell Non-Hodgkin's Lymphoma Drug Market Trends
 Table 11. B-Cell Non-Hodgkin's Lymphoma Drug Market Drivers
 Table 12. B-Cell Non-Hodgkin's Lymphoma Drug Market Challenges
 Table 13. B-Cell Non-Hodgkin's Lymphoma Drug Market Restraints
 Table 14. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Players (2020-2025)
 Table 16. Global Top B-Cell Non-Hodgkin's Lymphoma Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B-Cell Non-Hodgkin's Lymphoma Drug as of 2024)
 Table 17. Ranking of Global Top B-Cell Non-Hodgkin's Lymphoma Drug Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by B-Cell Non-Hodgkin's Lymphoma Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of B-Cell Non-Hodgkin's Lymphoma Drug, Headquarters and Area Served
 Table 20. Global Key Players of B-Cell Non-Hodgkin's Lymphoma Drug, Product and Application
 Table 21. Global Key Players of B-Cell Non-Hodgkin's Lymphoma Drug, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Type (2020-2025)
 Table 25. Global B-Cell Non-Hodgkin's Lymphoma Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Type (2026-2031)
 Table 27. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Application (2020-2025)
 Table 29. Global B-Cell Non-Hodgkin's Lymphoma Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Application (2026-2031)
 Table 31. North America B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Roche Company Details
 Table 47. Roche Business Overview
 Table 48. Roche B-Cell Non-Hodgkin's Lymphoma Drug Product
 Table 49. Roche Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)
 Table 50. Roche Recent Development
 Table 51. Gilead Sciences Company Details
 Table 52. Gilead Sciences Business Overview
 Table 53. Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Product
 Table 54. Gilead Sciences Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)
 Table 55. Gilead Sciences Recent Development
 Table 56. TG Therapeutics Company Details
 Table 57. TG Therapeutics Business Overview
 Table 58. TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Product
 Table 59. TG Therapeutics Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)
 Table 60. TG Therapeutics Recent Development
 Table 61. Bayer Company Details
 Table 62. Bayer Business Overview
 Table 63. Bayer B-Cell Non-Hodgkin's Lymphoma Drug Product
 Table 64. Bayer Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)
 Table 65. Bayer Recent Development
 Table 66. Secura Bio Company Details
 Table 67. Secura Bio Business Overview
 Table 68. Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Product
 Table 69. Secura Bio Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)
 Table 70. Secura Bio Recent Development
 Table 71. Epizyme Company Details
 Table 72. Epizyme Business Overview
 Table 73. Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Product
 Table 74. Epizyme Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)
 Table 75. Epizyme Recent Development
 Table 76. Eisai Company Details
 Table 77. Eisai Business Overview
 Table 78. Eisai B-Cell Non-Hodgkin's Lymphoma Drug Product
 Table 79. Eisai Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)
 Table 80. Eisai Recent Development
 Table 81. Acrotech Biopharma Company Details
 Table 82. Acrotech Biopharma Business Overview
 Table 83. Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Product
 Table 84. Acrotech Biopharma Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)
 Table 85. Acrotech Biopharma Recent Development
 Table 86. Teva Company Details
 Table 87. Teva Business Overview
 Table 88. Teva B-Cell Non-Hodgkin's Lymphoma Drug Product
 Table 89. Teva Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)
 Table 90. Teva Recent Development
 Table 91. Eagle Pharmaceuticals Company Details
 Table 92. Eagle Pharmaceuticals Business Overview
 Table 93. Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Product
 Table 94. Eagle Pharmaceuticals Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)
 Table 95. Eagle Pharmaceuticals Recent Development
 Table 96. MundiPharma Company Details
 Table 97. MundiPharma Business Overview
 Table 98. MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Product
 Table 99. MundiPharma Revenue in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)
 Table 100. MundiPharma Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. B-Cell Non-Hodgkin's Lymphoma Drug Picture
 Figure 2. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Type: 2024 VS 2031
 Figure 4. Oral Features
 Figure 5. Injection Features
 Figure 6. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Retail Pharmacy Case Studies
 Figure 10. Other Case Studies
 Figure 11. B-Cell Non-Hodgkin's Lymphoma Drug Report Years Considered
 Figure 12. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Region: 2024 VS 2031
 Figure 15. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Players in 2024
 Figure 16. Global Top B-Cell Non-Hodgkin's Lymphoma Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B-Cell Non-Hodgkin's Lymphoma Drug as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by B-Cell Non-Hodgkin's Lymphoma Drug Revenue in 2024
 Figure 18. North America B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Country (2020-2031)
 Figure 20. United States B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Country (2020-2031)
 Figure 24. Germany B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Region (2020-2031)
 Figure 32. China B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Country (2020-2031)
 Figure 40. Mexico B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Country (2020-2031)
 Figure 44. Turkey B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE B-Cell Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Roche Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
 Figure 48. Gilead Sciences Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
 Figure 49. TG Therapeutics Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
 Figure 50. Bayer Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
 Figure 51. Secura Bio Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
 Figure 52. Epizyme Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
 Figure 53. Eisai Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
 Figure 54. Acrotech Biopharma Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
 Figure 55. Teva Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
 Figure 56. Eagle Pharmaceuticals Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
 Figure 57. MundiPharma Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma Drug Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Non Hodgkin s Lymphoma Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Hodgkin Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lymphoma Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Hodgkin s Lymphoma and Chronic Lymphoma Treatment Market Research Report 2024
Global Follicular Lymphoma Drugs Market Research Report 2025
Global Follicular Lymphoma Treatment Market Research Report 2025
Global Non Hematological Cancers Market Research Report 2024
Lymphoblastic Lymphoma Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hematological Cancers Market Research Report 2024
Global Non Hematological Cancer Treatment Market Research Report 2024
Non Hodgkin Lymphoma Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hodgkin s Lymphoma Drugs Market Research Report 2024
Global Blood Tumor Drugs Market Research Report 2024
B Cell Non Hodgkin s Lymphoma NHL Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non small Cell Lung Cancer Drugs Market Insights Forecast to 2030
Global Blood Tumor Treatment Market Research Report 2024
Acute Lymphocytic Lymphoblastic Leukemia Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hematologic Malignancies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hematologic Malignancies Treatment Market Research Report 2024

RELATED REPORTS

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI Contouring Software for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32T20006
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cell Senescence β-Galactosidase Staining Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Q20500
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Kinase Inhibitors For Cancer Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-18V16958
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions